Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Net Change in Cash
Tibet Rhodiola Pharmaceutical Holding Co
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Net Change in Cash
-¥425.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Net Change in Cash
¥8.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Net Change in Cash
¥3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
125%
|
CAGR 10-Years
N/A
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Net Change in Cash
¥407m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Net Change in Cash
¥1.4B
|
CAGR 3-Years
54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Net Change in Cash
¥1.2B
|
CAGR 3-Years
32%
|
CAGR 5-Years
49%
|
CAGR 10-Years
25%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Net Change in Cash?
Net Change in Cash
-425.3m
CNY
Based on the financial report for Mar 31, 2024, Tibet Rhodiola Pharmaceutical Holding Co's Net Change in Cash amounts to -425.3m CNY.